InsiderSource
MRNA

Moderna, Inc.

SEC CIK 1682852
$49.91 +16.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$3.45M
4 open-market
Net insider flow
−$3.45M
Net selling
Filings shown
731
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at MRNA have sold a net $3.45M of stock (0 open-market buys vs 4 sells).

Largest recent trade: Flagship Ventures Fund Iv General Partner Llc sold $25.25M of MRNA, trimming their stake 2%.

Most active filer: Bancel Stephane, with 245 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for MRNA, newest first
View on SEC EDGAR ↗
MRNA
Moderna, Inc.
Tax withholding Hoge Stephen · President · Tax withholding · filed Mar 3, 2026
−$16.3K
316 sh @ $52
MRNA
Moderna, Inc.
Tax withholding Hoge Stephen · President · Tax withholding · filed Mar 3, 2026
−$15.3K
296 sh @ $52
MRNA
Moderna, Inc.
Tax withholding Hoge Stephen · President · Tax withholding · filed Mar 3, 2026
−$35.9K
695 sh @ $52
MRNA
Moderna, Inc.
Tax withholding Hoge Stephen · President · Tax withholding · filed Mar 3, 2026 ΔOwn −1.2%
−$928.3K
17,953 sh @ $52
Advertisement
MRNA
Moderna, Inc.
Option exercise Mock James M · Chief Financial Officer · Option exercise · filed Mar 3, 2026 ΔOwn +22%
+$0
9,901 sh
MRNA
Moderna, Inc.
Tax withholding Mock James M · Chief Financial Officer · Tax withholding · filed Mar 3, 2026 ΔOwn −0.4%
−$8.3K
160 sh @ $52
MRNA
Moderna, Inc.
Tax withholding Mock James M · Chief Financial Officer · Tax withholding · filed Mar 3, 2026 ΔOwn −0.8%
−$19.4K
375 sh @ $52
MRNA
Moderna, Inc.
Tax withholding Mock James M · Chief Financial Officer · Tax withholding · filed Mar 3, 2026 ΔOwn −8.6%
−$247.6K
4,788 sh @ $52
MRNA
Moderna, Inc.
Option exercise Hoge Stephen · President · Option exercise · filed Feb 25, 2026 ΔOwn +7.7%
+$2.14M
111,679 sh @ $19
MRNA
Moderna, Inc.
Option exercise Hoge Stephen · President · Option exercise · filed Feb 25, 2026 ΔOwn +3.1%
+$925.5K
48,330 sh @ $19
MRNA
Moderna, Inc.
Sell Hoge Stephen · President · Open-market sale · filed Feb 25, 2026 ΔOwn −9.9%

Hoge Stephen sold $7.81M of MRNA, trimming their stake 10%.

−$7.81M
160,009 sh @ $49
MRNA
Moderna, Inc.
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Dec 15, 2025 ΔOwn −86%

Afeyan Noubar sold $703.3K of MRNA, trimming their stake 86%.

−$703.3K
23,853 sh @ $29
MRNA
Moderna, Inc.
Sell Hussain Abbas · Director · Open-market sale · filed Dec 11, 2025 ΔOwn −25%

Hussain Abbas sold $13.9K of MRNA, trimming their stake 25%.

−$13.9K
504 sh @ $28
MRNA
Moderna, Inc.
Sell Hussain Abbas · Director · Open-market sale · filed Jun 12, 2025 ΔOwn −35%

Hussain Abbas sold $8.7K of MRNA, trimming their stake 35%.

−$8.7K
312 sh @ $28
MRNA
Moderna, Inc.
Buy Bancel Stephane · Director, Chief Executive Officer · Open-market purchase · filed Mar 4, 2025 ΔOwn +1.1%

Bancel Stephane, MRNA's CEO, spent $3.19M of their own money on 102,821 shares at $31, growing their stake 1%.

+$3.19M
102,821 sh @ $31
MRNA
Moderna, Inc.
Buy Bancel Stephane · Director, Chief Executive Officer · Open-market purchase · filed Mar 4, 2025 ΔOwn +0.6%

Bancel Stephane, MRNA's CEO, spent $1.81M of their own money on 57,493 shares at $32, growing their stake 1%.

+$1.81M
57,493 sh @ $32
MRNA
Moderna, Inc.
Sell Klinger Shannon Thyme · Chief Legal Officer · Open-market sale · filed Dec 10, 2024 ΔOwn −2.5%

Klinger Shannon Thyme sold $23.6K of MRNA, trimming their stake 3%.

−$23.6K
529 sh @ $45
MRNA
Moderna, Inc.
Sell Klinger Shannon Thyme · Chief Legal Officer · Open-market sale · filed Dec 4, 2024 ΔOwn −0.6%

Klinger Shannon Thyme sold $4.8K of MRNA, trimming their stake 1%.

−$4.8K
112 sh @ $43
MRNA
Moderna, Inc.
Sell Hoge Stephen · President · Open-market sale · filed Dec 4, 2024

Hoge Stephen sold $13.6K of MRNA.

−$13.6K
314 sh @ $43
MRNA
Moderna, Inc.
Sell Mock James M · Chief Financial Officer · Open-market sale · filed Dec 2, 2024 ΔOwn −11%

Mock James M sold $60.8K of MRNA, trimming their stake 11%.

−$60.8K
1,420 sh @ $43
MRNA
Moderna, Inc.
Sell Klinger Shannon Thyme · Chief Legal Officer · Open-market sale · filed Dec 2, 2024 ΔOwn −6.7%

Klinger Shannon Thyme sold $60.7K of MRNA, trimming their stake 7%.

−$60.7K
1,418 sh @ $43
MRNA
Moderna, Inc.
Sell Hoge Stephen · President · Open-market sale · filed Dec 2, 2024

Hoge Stephen sold $12.5K of MRNA.

−$12.5K
291 sh @ $43
MRNA
Moderna, Inc.
Sell Hoge Stephen · President · Open-market sale · filed Nov 12, 2024

Hoge Stephen sold $12.8K of MRNA.

−$12.8K
277 sh @ $46
MRNA
Moderna, Inc.
Sell Mock James M · Chief Financial Officer · Open-market sale · filed Oct 8, 2024 ΔOwn −7.0%

Mock James M sold $43K of MRNA, trimming their stake 7%.

−$43K
715 sh @ $60
MRNA
Moderna, Inc.
Sell Klinger Shannon Thyme · Chief Legal Officer · Open-market sale · filed Sep 10, 2024 ΔOwn −2.9%

Klinger Shannon Thyme sold $40.5K of MRNA, trimming their stake 3%.

−$40.5K
551 sh @ $74
Advertisement

About MRNA insider activity

This page tracks every recent Form 4 filed for Moderna, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is MRNA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Moderna, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.